CN
205-277-3
应用筛选条件
关键词:'205-277-3'
显示 1-30 共 118 条结果 关于 "205-277-3" 范围 技术文档
Quality Control Ranges: Milliplex Human Cytokine / Chemokine Immunoassay
pg/mL
IL-2 Control 1 99 – 205 pg/mL MIP-1β Control 1 93 – 193 pg/mL
Control 2 492 – 1021 pg/mL Control 2
Quality Control Range Sheet- HCC-121A and HCC-221A
pg/mL
IL-2 Control 1 99 – 205 pg/mL MIP-1β Control 1 93 – 193 pg/mL
Control 2 492 – 1021 pg/mL Control 2
Data Sheet - SAB4200281
al., J. Biol. Chem., 277, 41872-41878
(2002).
2. Braunewell, K-H., and Klein-Szanto A.J., Cell
Tissue Res., 335, 301-316 (2009).
3. Paterlini, M., et al., Neurosci., 99, 205-216 (2000).
4. Spilker
Product Information Sheet - A1355
et al., J. Cell Biol., 139,
1255-1269 (1997).
3. Pope, R.K., et al., Genomics, 52, 342-351
(1998).
4. Nebl, T., et al., J. Biol. Chem., 277, 43399-
43409 (2002).
5. Wulfkuhle, J.D., et al
Data Sheet - S8695
bovine neutrophils.1, 2 Supervillin has two
isoforms of reported 205/250 kDa. The longer isoform
named archvillin is muscle specific.3 Supervillin is a
tightly bound peripheral membrane protein that
Product Information Sheet - T0625
oxygen
species: amino acyl chloramines mediate
hypochlorous acid-induced apoptosis. J. Biol.
Chem., 277(23), 20518-20526 (2002).
10. Yazdanbakhsh, M., et al., Killing of schistosomula
by taurine
Product Information Sheet - P6623
., Biol. Rep., 60, 1402-1409
(1999).
3. Matsushima-Nishiwaki, R., et al., Cancer Res., 61,
7675-7682 (2001).
4. Zama, T., et al., J. Biol. Chem., 277,
23909-23918 (2002).
5. Coronella-Wood
Data Sheet - L2670 - Lot 041M0978
glycerol.
Molecular mass: ∼85 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 205–277 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not
Data Sheet - L2670 - Lot 109K0837
glycerol.
Molecular mass: ∼85 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 205–277 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not
Data Sheet - L2670 - Lot SLBB2794
glycerol.
Molecular mass: ∼85 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 205–277 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not
CDK1/CyclinA2 active (C0244)
with hypericin involves a CDK1-mediated
signal and delays the onset of apoptosis. J. Biol.
Chem., 277, 37718-37731 (2002).
2. Rigas, A.C. et al., Therapeutic potential of CDK
inhibitor NU2058 in androgen-independent
CDK1/CyclinA2 Active (C0244)
with hypericin involves a CDK1-mediated
signal and delays the onset of apoptosis. J. Biol.
Chem., 277, 37718-37731 (2002).
2. Rigas, A.C. et al., Therapeutic potential of CDK
inhibitor NU2058 in androgen-independent
CDK1/CyclinA2 Active (C0244)
with hypericin involves a CDK1-mediated
signal and delays the onset of apoptosis. J. Biol.
Chem., 277, 37718-37731 (2002).
2. Rigas, A.C. et al., Therapeutic potential of CDK
inhibitor NU2058 in androgen-independent
Data Sheet - C0244 - Lot 011M0792
with hypericin involves a CDK1-mediated
signal and delays the onset of apoptosis. J. Biol.
Chem., 277, 37718-37731 (2002).
2. Rigas, A.C. et al., Therapeutic potential of CDK
inhibitor NU2058 in androgen-independent
Data Sheet - C0244
with hypericin involves a CDK1-mediated
signal and delays the onset of apoptosis. J. Biol.
Chem., 277, 37718-37731 (2002).
2. Rigas, A.C. et al., Therapeutic potential of CDK
inhibitor NU2058 in androgen-independent
Data Sheet - C0244 - Lot 031M0754
CDK1 ∼59 kDa
CyclinA2 ∼78 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 151–205 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not for
Data Sheet - C0244 - Lot 071M0782
CDK1 ∼59 kDa
CyclinA2 ∼78 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 151–205 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not for
Data Sheet - C0244 - Lot SLBB7921V
CDK1 ∼59 kDa
CyclinA2 ∼78 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 151–205 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not for
Product Information Sheet - 4739205001
Microarray RNA Target Synthesis Kit (T7)*
Biotin-ε- aminocaproyl-[5-(3-aminoallyl)-cytidine-5’-triphosphate] disodium salt
Cat. No. 04 739 205 001 y Version 04
250 nmol (25 µl) 10 mM Content version: August
XP725 Antibody Number-Lot Number 071M4826
272
3.3 201 202 203 204 225 226 227 228 249 250 251 252 273 274 275 276
3.4 205 206 207 208 229 230 231 232 253 254 255 256 277 278 279 280
3.5 209 210 211 212 233 234 235
Fast and accurate peptide quantitation using the Direct Detect®spectrometer
protein protocols handbook,
Humana Press 1996: 3-6.
3. Scopes, R.K. Measurement of protein by spectrophotometry at 205 nm. Anal. Biochem. 1974, 59: 277-282.
4. Jackson M. and Mantsch H.H. The use and
Antibody Sourcebookﾙ Sixth Edition
-Caldesmon Mouse mAb (TD107) FS, IB, IC human ST1109 50 µg €149
Anti-CAD (205-221) Rabbit pAb IB mouse 20554� 100 µg €277
Anti-E-Cadherin (ECCD-1) Rat mAb (ECCD-1) CIA mouse; not bovine, not canine
LABORATORY NOTEBOOK ISSUANCE PAGE
Francium Fr 87 [223]
Gadolinium Gd 64 157.25(3)
Gallium Ga 31 69.723(1)
Germanium Ge 32 72.63(1)
Gold Au 79 196.966 569(4)
Hafnium Hf 72 178.49(2)
Hassium Hs 108 [277]
Helium He 2 4.002 602(2)
Holmium Ho 67
LABORATORY NOTEBOOK ISSUANCE PAGE
Francium Fr 87 [223]
Gadolinium Gd 64 157.25(3)
Gallium Ga 31 69.723(1)
Germanium Ge 32 72.63(1)
Gold Au 79 196.966 569(4)
Hafnium Hf 72 178.49(2)
Hassium Hs 108 [277]
Helium He 2 4.002 602(2)
Holmium Ho 67
LABORATORY NOTEBOOK ISSUANCE PAGE
34.6 –116 –40 0.24 4.34 218 1.353
Ethyl acetate 0.902 77 –84 –3 0.46 6.02(25) 256 1.372
Ethyl alcohol 0.816 78 –114 16 1.10(25) 24.55(25) 205 1.363
Ethylene glycol dimethyl ether
(or monoglyme) 0.867 85
Lab Notebook Guidelines
34.6 –116 –40 0.24 4.34 218 1.353
Ethyl acetate 0.902 77 –84 –3 0.46 6.02(25) 256 1.372
Ethyl alcohol 0.816 78 –114 16 1.10(25) 24.55(25) 205 1.363
Ethylene glycol dimethyl ether
(or monoglyme) 0.867 85
PKH Dye Reference Guide
thymocytes in vivo: characterization of a
CD3-4+8- intermediate. J.Exp.Med. 1993;
178: 265-277.
131. Ladel CH, Kaufmann SH, Bamberger U:
Localisation of human peripheral blood
leukocytes after
Product Information Sheet - SH2821
phagocytosis. Methods,
44, 205-21 (2008).
2. Howley, B., and Fearnhead, H.O., Caspases as
therapeutic targets. J. Cell Mol. Med., Feb 24 [Epub
ahead of print] (2008).
3. Logue, S.E., and Martin
Product Information Sheet - SH0821
phagocytosis. Methods,
44, 205-21 (2008).
2. Howley, B., and Fearnhead, H.O., Caspases as
therapeutic targets. J. Cell Mol. Med., Feb 24 [Epub
ahead of print] (2008).
3. Logue, S.E., and Martin
Product Information Sheet - SH2721
phagocytosis. Methods,
44, 205-21 (2008).
2. Howley, B., and Fearnhead, H.O., Caspases as
therapeutic targets. J. Cell Mol. Med., Feb 24 [Epub
ahead of print] (2008).
3. Logue, S.E., and Martin
1/4